Voglio sapere a riguardo di…

52819

Presidential Documents
Federal Register Vol. 86, No. 181
Wednesday, September 22, 2021

Title 3

Presidential Determination No. 202113 of September 15, 2021

The President
Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2022
Memorandum for the Secretary of State By the authority vested in me as President by the Constitution and the laws of the United States, including section 7061 of the Foreign Relations Authorization Act, Fiscal Year 2003 Public Law 107228 FRAA, I hereby identify the following countries as major drug transit or major illicit drug producing countries: Afghanistan, The Bahamas, Belize, Bolivia, Burma, Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan, Panama, Peru, and Venezuela.
A countrys presence on the foregoing list is neither a reflection of its governments counterdrug efforts nor level of cooperation with the United States. Consistent with the statutory definition of a major drug transit or major illicit drug producing country set forth in section 481e2 and 5
of the Foreign Assistance Act of 1961, as amended Public Law 87195
FAA, the reason countries are placed on the list is the combination of geographic, commercial, and economic factors that allow drugs to be transited or produced, even if a government has engaged in robust and diligent narcotics control and law enforcement measures.
Pursuant to section 7062A of the FRAA, I hereby designate Bolivia and Venezuela as having failed demonstrably to make substantial efforts during the previous 12 months to both adhere to their obligations under international counternarcotics agreements and to take the measures required by section 489a1 of the FAA. Included with this determination are justifications for the designations of Bolivia and Venezuela, as required by section 7062B
of the FRAA. I have also determined, in accordance with provisions of section 7063A of the FRAA, that United States programs that support Bolivia and Venezuela are vital to the national interests of the United States.
The ongoing drug addiction and overdose epidemic in the United States is one of the foremost public health priorities of my Administration, and addressing this epidemic will require both new domestic investments and greater cooperation with foreign partners to target illicit drug suppliers and the criminal organizations that profit from them. While creating our firstyear drug policy priorities, my Administration outlined a strategy that includes expanding access to prevention, treatment, evidence-based harm reduction, and recovery support services in order to curb the drug addiction and overdose epidemic. The American Rescue Plan Act of 2021 is an investment in these priorities, committing nearly $4 billion to support behavioral health and substance use disorder programs.
My Administrations Fiscal Year 2022 Budget request itemizes $10.7 billion to support research, prevention, treatment, evidence-based harm reduction, and recovery support services, with targeted investments to meet the needs of populations at greatest risk for overdose and substance use disorder.
The Budget request also includes significant investments to reduce the supply of illicit drugs originating from beyond our borders.
The United States is committed to working together with the countries of the Western Hemisphere as neighbors and partners to meet our shared challenges of drug trafficking and use. My Administration will seek to expand
VerDate Sep<11>2014

17:52 Sep 21, 2021

Jkt 253250

PO 00000

Frm 00003

Fmt 4705

Sfmt 4790

E:FRFM22SEO0.SGM

22SEO0